Artigo original/original Article

Similar documents
Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE

European IVF Monitoring (EIM) Year: 2013

European IVF Monitoring (EIM) Year: 2012

Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE

MONITORING ASSISTED REPRODUCTIVE TECHNOLOGIES ROMANIAN EXPERIENCE

Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE

Assisted Reproductive Technology National Summary Report Belgium 2015

Births following fertility treatment in the GUI infant cohort. Aisling Murray Growing Up in Ireland, ESRI

Is meaningful reporting of national IVF outcome data possible?

JAWDA Quarterly & Yearly Guidelines for Assisted Reproductive Technology Treatment (ART) Providers January 2019

Demographic relevancy of increased use of assisted reproduction in European countries

FIVNAT-CH Schweizerische Gesellschaft für Reproduktionsmedizin Société Suisse de Médecine de la Reproduction

International Federation of Fertility Societies. Global Standards of Infertility Care

Risk of congenital anomalies in children born after frozen embryo transfer with and without vitrification

Commissioning Policy For In Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) within Tertiary Infertility Services

Demographic relevancy of increased use of assisted reproduction in European countries

Results of Assisted Reproductive Technology in 2001 generated from the Middle East IVF registry

Fertility treatment in trends and figures

Original Effect of A Time-lapse Incubator (EmbryoScope ) on in vitro Culture of Human Embryos

WHAT IS A PATIENT CARE ADVOCATE?

December 2015, Volume: 7, Issue: 8, Pages: , DOI:

ART in Europe, 2014: results generated from European registries by ESHRE

WHO ARE THE DONORS? - An HFEA Analysis of donor registrations and use of donor gametes over the last 10 years

Fertility treatment in trends and figures

Haringey CCG Fertility Policy April 2014

A world apart? IVF in Europe and the USA

Intrauterine (IUI) and Donor Insemination (DI) Policy (excluding In vitro fertilisation (IVF) & Intracytoplasmic sperm injection (ICSI) treatment)

Biology of fertility control. Higher Human Biology

1 - Advanced clinical course for ART with Hands on

CLINICAL RESULTS 2016

Incomplete working draft, please do not quote without authors permission

Society for Assisted Reproductive Technology and American Society for Reproductive Medicine

NHS FUNDED TREATMENT FOR SUBFERTILITY. ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs

Recommended Interim Policy Statement 150: Assisted Conception Services

Fertility treatment and referral criteria for tertiary level assisted conception

SHIP8 Clinical Commissioning Groups Priorities Committee (Southampton, Hampshire, Isle of Wight and Portsmouth CCGs)

NICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic

Infant and maternal health monitoring using a combined Nordic database on ART and safety

Adoption and Foster Care

COMMISSIONING POLICY. Tertiary treatment for assisted conception services

Fertility Policy. December Introduction

2017 United HealthCare Services, Inc.

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.

Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHRE

ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE

PhD THESIS SARA SOFIA MALCHAU LAUESGAARD ACADEMIC SUPERVISORS

Your consent to donating your eggs

Understanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre

IVF. NHS North West London CCGs

CLINICAL RESULTS 2017.

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES

Analysis of factors affecting embryo implantation

FERTILITY PRESERVATION. Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida

Update on revisions to the ICMART / WHO glossary

Assisted Reproductive Technologies

East and North Hertfordshire CCG. Fertility treatment and referral criteria for tertiary level assisted conception

Use of donor semen in the treatment of

West Hampshire Clinical Commissioning Group Board

Fertility Services Commissioning Policy

Fertility Services Commissioning Policy (Level 3)

Public consultation: Seeking your views on IVF

Yes infertility policy pdf

Infertility treatment

Clinical Policy Committee

Assisted Conception Policy

HALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY. CONTENTS Page

INFERTILITY SERVICES

Your consent to the use of your sperm in artificial insemination

Embryo Selection after IVF

Assisted Reproductive Technologies

Trends in Egg Donation. Vitaly A. Kushnir MD Center for Human Reproduction

Understanding IVF Processes in Surrogacy

Egg donation resort: the Spanish position? Valérie Vernaeve, MD PhD

Men s consent to the use and storage of sperm or embryos for surrogacy

Clinical Policy Committee

The New England Journal of Medicine

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.

Fertility Services Commissioning Policy

Abstract. Introduction. Materials and methods. Patients and methods

LCCG Fertility Services Commissioning Policy

Universal Embryo Cryopreservation: Frozen versus Fresh Transfer. Zaher Merhi, M.D.

Approved January Waltham Forest CCG Fertility policy

Maximizing the Yield of Assisted Reproductive Technologies at Every Step

Couples Information Leaflet

NHS WEST ESSEX CLINICAL COMMISSIONING GROUP. Fertility Services Commissioning Policy Policy No. WECCG89. This policy replaces all previous versions.

Bromley CCG Assisted Conception Funding Form Checklist for Eligibility Criteria for NHS funding of Assisted Conception

Fertility treatment and referral criteria for tertiary level assisted conception

Sperm Donation - Information for Donors

IVF MONEY-BACK PLAN. More information about payment options? IN PARTNERSHIP WITH. Call Access Fertility or visit their website

INTRACYTOPLASMIC SPERM INJECTION

Fertility Services Commissioning Policy

Assisted Conception Policy

The evidence for insemination versus intercourse or IVF

Criteria for NHS Funded Assisted Conception Treatments for Sub-fertility For CCGs within East Sussex

Blackpool CCG. Policies for the Commissioning of Healthcare. Assisted Conception

Policy updated: November 2018 (approved by Haringey and Islington s Executive Management Team on 5 December 2018)

North Staffordshire Clinical Commissioning Group. Infertility and Assisted Reproduction Commissioning Policy and Eligibility Criteria

Policy statement. Commissioning of Fertility treatments

Opinion no. 67 of 12 September 2016 on the reception of eggs harvested from the partner within lesbian couples with a view to in vitro fertilisation

Transcription:

Artigo original/original Article Análise do registo português de procriação medicamente assistida: 1997-2005 A long-term analysis of the Portuguese assisted reproductive technologies data registry 1997-2005 Vladimiro Silva *, Carlos Calhaz-Jorge ** AbStRACt Overview and Aims: This report includes data from the Portuguese Assisted Reproductive Technologies (ART) Data Registry concerning procedures performed between the beginning of 1997 and the end of 2005. Study Design: Registries published according to the directives of the European Society for human Reproduction and Embryology EShRE S in vitro fertilisation Monotoring Consortium. Population: Patients submitted to ART in participating centres. Methods: Data were collected on a voluntary and trust basis and published as annual aggregated reports. Results: There was an increase in both the utilization and the success rates of ART in Portugal, with ART children already contributing to almost 1% of total annual births in the country. On the other hand, the total number of cycles is still far from the European average. The number of embryos transferred per cycle has been decreasing, as is the case of the proportion of multiple pregnancies, even though the twin birth rate is still above 20%. Procedures such as frozen embryo replacement and intra-uterine insemination have proven to be useful and trustworthy, whilst pre-implantation genetic diagnosis and oocyte donation are rarely performed. Results from pre-implantation genetic diagnosis still lack consistency. Conclusions: National ART registries are becoming progressively more representative and provide useful information about the outcomes of ART procedures in the country. introduction Since the creation of the National Assisted Reproductive Technologies (ART) Data Registry in 1997, data have been submitted from most of the clinics performing fertility treatments in Portugal. This information has been collected using paper forms, which were keyed by one of the authors (CCJ responsible for the Portuguese Society for Reproductive Medicine Data Registry Programme) into a database. Those data were used as the Portuguese contribution to the European registry by the European IVF Monitoring Consortium (EIM), under the auspices of the European Society for human Reproduction and Embryology (EShRE). Since the EIM meeting in Madrid 2003, it was decided that in the coming years its members should consider the deinitions listed by the International * Responsável pelo Laboratório de Embriologia e Andrologia, Ferticentro, Coimbra ** Coordenador do Sector de Ginecologia e Responsável da unidade de Reprodução humana, hospital de Santa Maria, Lisboa 25

Silva V, Calhaz-Jorge C Committee Monitoring ART (ICMART) as originally published in the WhO report 1 and endorsed by EShRE and the American Society of Reproductive Medicine 2,3. According to the ICMART/WHO deinitions, IuI-h (intra-uterine insemination using partner s sperm) and IuI-D (intra-uterine insemination with donor sperm) should not be classiied as ART. However, the EIM Consortium has decided to include the IuI activity in the annual reports since 2001. The reasons are that these treatments are frequently used, they give a contribution to the annual birth rates and include risks like multiple gestations and ethical concerns as when donor sperm is used 4. Moreover, the recently published Portuguese law on ART (Law 32/2006) considers IuI as an ART procedure. Data reporting has been made from each clinic on a voluntary and trust basis, since there is no auditing process associated to the Registry. Even though the number of participating centers has increased through time, the Portuguese National ART Data Registry has never been complete, since some clinics do not report data concerning their activity (Table I). Table I Percentage of participation in the Portuguese ART registry. Clinics Clinics in Percentage of Year reporting the country participation 1997 4 NA NA 1998 6 NA NA 1999 8 13 61.5% 2000 11 16 68.8% 2001 9 20 45.0% 2002 14 20 70.0% 2003 17 19 89.5% 2004 17 19 89.5% 2005 18 20 90.0% material ANd methods The present report summarizes data from ART treatments started from January 1 st, 1997 to December 31 st, 2005. Data include treatments with In Vitro Fertilisation (IVF), Intra-Cytoplasmatic Sperm Injection (ICSI), Frozen Embryo Replacement (FER), Pre-implantation Genetic Diagnosis (PGD), IuI-h and IuI-D. Followup data on pregnancies and deliveries are cohort data. For IuI, data is only available since 2001 and only pregnancies and not deliveries were recorded. As it is evident from the tables, there are some missing numbers. This concerns especially later stages of pregnancy and is the result of the dificulties of some clinics to provide complete information. The high number of cases lost to follow-up may lead to an underestimation of the live birth rates. however, its effect on pregnancy rates is less likely to be signiicant. As the data presented here are incomplete and generated from different clinics without any veriication process, interpretation of this information must be done with some caution. RESuLtS Size of ART clinics reporting to the Registry Described in Table II. Table II Size of the clinics (cycles per year, excluding IuI) reporting to the Portuguese ART Registry. Cycles per year Year < 50 50-99 100-199 200-500 > 500 Total 1997 0 2 1 1 4 1998 2 2 1 1 6 1999 2 1 4 1 8 2000 3 4 3 1 11 2001 2 1 5 1 9 2002 2 4 2 5 1 14 2003 3 4 5 4 1 17 2004 2 3 7 4 1 17 2005 1 4 5 7 1 18 Number of treatment cycles Since the introduction of the Registry in 1997, there has been an increase in the number of treatment cycles reported, with the exception of the year 2004 (which can be partially explained by the fact that two of the biggest centres were not able to participate in that year s Registry) (Table III). There is a tendency towards increasing the proportion of ICSI treatment cycles through the years, with the exception of 2004 (Figure 1). 26

Table III Number and proportion of treatment cycles in clinics reporting to the Portuguese ART Registry. Year IVF ICSI FER IUI IVF+ICSI IVF+ICSI+FER+IUI IVF/ICSI 1997 NA NA NA NA NA 1183* NA 1998 512 646 59 NA 1158 1217 44.2% 55.8% 1999 735 886 139 NA 1621 1760 45.3% 54.7% 2000 896 1063 120 NA 1959 2079 45.7% 54.3% 2001 835 1160 213 887 1995 3095 41.9% 58.1% 2002 1023 1518 391 1259 2541 4191 40.3% 59.7% 2003 1054 1658 364 1210 2712 4286 38.9% 61.1% 2004 798 1078 368 1214 1876 3458 42.5% 57.5% 2005 1223 1821 361 1583 3044 4988 40.2% 59.8% *Only IVF+ICSI+FER. NA Not Available. Figure 1. Proportion between IVF and ICSI in the Portuguese ART Registry. Figure 2. ART cycles by women s age group in the Portuguese ART Registry, 2000-2005. 27

Silva V, Calhaz-Jorge C Figure 3. Pregnancy rates per embryo transfer by women s age group in the Portuguese ART Registry, 2000-2005 (years with comparable data available). Patient s age Figure 2 shows the number of women having ART treatments, divided by age group. Apparently there s no trend towards older or younger ages, with the relative proportion of each age group remaining stable. The number of IVF/ICSI cycles has been generally increasing in all age groups. Pregnancy rates for all IVF & ICSI treatment cycles by age group of patient using fresh embryos As expected, pregnancy rates decrease with women s age group (Figure 3). Figure 4 shows how pregnancy rates per embryo transfer have improved over the years for all patients age groups (donor cycles were excluded). Figure 4. Pregnancy rate by women s age group over the years. 28

Figure 5. Infertility factors by year, IVF + ICSI, in fresh cycles, 1998-2005. Figure 6. Infertility factors in IVF and ICSI fresh cycles, 1998-2005. Infertility factors Apparently there is no trend towards the relative variation of any infertility factor along the study period, since all the lines in Figure 5 are generally overlapped. As expected, IVF and ICSI patients have important differences in the proportion of the infertility factors (Figure 6). Number of embryos transferred after IVF/ICSI In recent years, a trend towards a lower number of embryos transferred has been observed, as shown in Figure 7. The proportion of single embryo transfer (SET) cycles has always accounted for less than 20% of total embryo transfers and remained stable. It is not 29

Silva V, Calhaz-Jorge C Figure 7. Number of embryos transferred in IVF/ICSI cycles using own eggs, 1998-2005. Figure 8. Proportion of cycles where 1, 2, 3 or more embryos have been transferred. possible to extract information about the proportion (if any) of elective single embryo transfers (eset) from our database. The proportion of 2-embryos transfers has been increasing, whilst the number of transfers of 3 or more embryos has dramatically decreased (Figure 8). The number of embryos transferred in each IVF or ICSI cycle increases the pregnancy rate only until a certain point, with no apparent relevant success gains above 2 embryo transfers (Figure 9). however, this effect has only been clear since 2002. Pregnancy, live birth and multiple birth rates for IVF/ICSI treatment cycles Figure 10 provides clinical pregnancy rates of IVF/ ICSI cycles performed using couple s eggs (frozen embryo transfers are not included). There is a tendency towards an improvement in IVF results (better than ICSI for 7 consecutive years). ICSI pregnancy rates are also rising, but the slope of the trendline is lower. The very high number of cases lost to follow-up turns live birth rate an indicator of limited value in the case of the Portuguese ART Registry. Values recorded are there- 30

Figure 9. Pregnancy rates by number of embryos transferred. Figure 10. Clinical pregnancy per embryo transfer in IVF/ICSI cycles using own eggs. fore lower than expected and probably have no direct correlation with registered pregnancy rates (Figure 11). Even though there is a tendency towards diminishing the number of triplets, the proportion of twins remains above 20% (Figure 12). Pregnancy, live birth and multiple birth rates for FER treatment cycles Table IV provides the number of FER cycles together with their pregnancy outcomes. The number of transfers in FER cycles has been increasing through the 31

Silva V, Calhaz-Jorge C Figure 11. Live birth rate per embryo transfer in IVF/ICSI cycles using own eggs. Figure 12. Multiple births after IVF/ICSI using own eggs. Table IV. FER outcomes, 1997-2005. Thawings Transfers Pregnancies Pregnancy/embryo transfer 1997 48 40 5 12.5% 1998 NA 59 12 20.3% 1999 139 128 20 15.6% 2000 120 107 19 17.8% 2001 213 198 21 10.6% 2002 391 333 52 15.6% 2003 364 340 71 20.9% 2004 368 330 58 17.6% 2005 506 395 89 22.5% 32

years, being in 2005 almost ten-fold the value recorded in 1997. however, pregnancy rates have only experienced a slight increase in recent years. In this table all cycles are included, regardless of their origin from IVF or ICSI. Children born after ART Table V shows the number of ART infants expressed in percentage of the total number of live-born in the country. ART (considered only as IVF+ICSI fresh cycles) contribution to total births is surely underestimated, as stated before. Due to this data limitation, we tried to infer the number of infants from the number of pregnancies, considering a pregnancy loss rate of 15% (all causes). Therefore, this information is only an estimate and should be interpreted with caution. IUI pregnancy and live birth rates Described in Table VI and Figure 13. Table V. ART contribution to total births. Estimated Recorded % Number of Triplets number of number of National estimated pregnancies Singletons Twins or more infants born infants born births ART infants 1997 203 77.6% 16.4% 6.0% 222 NA 113047 0.20% 1998 238 72.8% 21.9% 5.3% 268 256 113510 0.24% 1999 255 69.4% 28.0% 2.6% 289 275 116038 0.25% 2000 395 71.0% 23.6% 5.4% 451 NA 120071 0.38% 2001 423 71.2% 24.6% 4.2% 478 444 112825 0.42% 2002 602 74.4% 23.7% 1.9% 652 535 114456 0.57% 2003 666 71.0% 25.9% 3.1% 748 670 112589 0.66% 2004 651 75.1% 23.7% 1.3% 698 563 109356 0.64% 2005 937 77.5% 21.2% 1.2% 985 894 109457 0.90% Table VI. IuI outcomes, 2001-2005. IUI using partner s sperm IUI using donor s sperm Women s age <40 years ³ 40 years <40 years ³ 40 years Clinical Clinical Clinical Clinical Number pregnancy Number pregnancy Number pregnancy Number pregnancy of cycles rate of cycles rate of cycles rate of cycles rate 2001 672 12.5% 16 18.75% 196 18.4% 3 0.0% 2002 993 12.9% 38 10.5% 214 22.4% 14 7.1% 2003 954 12.8% 54 16.7% 201 24.4% 1 0.0% 2004 961 13.1% 57 8.8% 194 23.7% 2 0.0% 2005 1320 11.5% 46 2.2% 216 22.7% 1 0.0% Adverse outcomes: complications There are very few reports of adverse outcomes in ART treatments. From 2000 to 2005 there were 98 cases of hyperstimulation ovarian syndrome, 4 cases of bleeding and 4 cases of infection. PGD National activity on PGD is still very low, since there were only 6 PGD pregnancies until the end of 2005. The annual number of aspirations and embryo transfers is also very low, which is especially relevant since in this particular technique the National ART Registry is likely to be complete and fully representative of the country s reality (Table VII). Oocyte donation As for PGD, oocyte donation cycles in Portugal have very little expression in the period considered 33

Silva V, Calhaz-Jorge C Figure 13. IuI success rates 2001-2005. Table VII. PGD activity in Portugal. Embryo Pregnancy rate/ Aspirations transfers /Embryo transfer 2000 4 2 0.0% 2001 14 16 6.3% 2002 12 8 0.0% 2003 14 10 10.0% 2004 21 16 12.5% 2005 28 18 11.1% Total: 93 70 8.6% (Table VIII). Even though the achieved pregnancy rates per embryo transfer are very good, there is a high proportion of pregnancy losses. This cannot be explained with deiciencies in pregnancies followup, since the available information is complete. discussion The National ART Data Registry is becoming more complete and representative through the years, reaching a maximum of 90% of the centres in 2005, which is likely to represent an even greater proportion of the number of cycles performed in Portugal. Two points deserve some comments. Firstly, there was in fact an increase in the number of ART centres in the country along the years Table VIII Oocyte donation cycles in Portugal, 2002-2005. Initiated Embryo Pregnancy rate/ Delivery rate/ Cycles transfers /Embryo transfer /Initiated cycle 2002 11 6 83.3% 36.4% 2003 15 13 53.8% 26.7% 2004 24 21 57.1% 33.3% 2005 37 28 57.1% 24.3% but the substantial increase seen in reporting clinics until 2003 represents above all that the clinics understood the importance of contributing to a national registry. Secondly, Portuguese ART centres are globally of small dimension with only one centre performing more than 500 treatment cycles annually and an important number performing less than one hundred cycles per year. Total number of cycles has also been increasing through the years, but its maximum value (3044 cycles in 2005, which roughly corresponds to 300 cycles/ million population) is still below the 1166 cycles/mil- lion population averaged by the European countries with complete registries that participated in the last EShRE registry 4. And of course very distant from the international standard of 1500 cycles/million population/year proposed by the EhRE Capri Workshop Group in 2001 5, which applied to Portugal would correspond to approximately 15,000 cycles/year. 34

There is a tendency towards increasing the proportion of ICSI treatment cycles through the years, with the exception of 2004. This is consistent with reports from other countries 7-8 and has no obvious explanation. ICSI, IVF and FER pregnancy rates have also been generally increasing and now present values similar to the European average 4. Even though the number of cycles is below other countries, the proportion of ART children is certainly close to 1% of total national births, not so far from the values registered in some European countries (1-5% according to Nyboe-Andersen et al, 2008 4 ). The number of multiple embryo transfers has been decreasing and there s a clear trend to the rise in 2 embryos transfers. The proportion of SET has remained stable, which probably means that there are no signiicant eset policies among participating centres. As a consequence, the number of triplets has also been dramatically reduced, even though the twin birth proportion is still above 20%. The number of embryos transferred in each IVF/ICSI cycle increases the pregnancy rate only until 2 embryos transfers, which has only been clear since 2002. IuI success rates are similar to other countries and clearly below those of IVF and ICSI, especially for women over 40 years, among whom the pregnancy rate has clearly diminished. There were 106 cases of adverse outcomes reported in 14,127 cycles (0.75%) between 2000 and 2005. It is possible that this number results from underreporting. There are very few PGD and oocyte donation (OD) cycles, which could explain the lack of consistency of these procedures reported results. In the irst case, that is likely to happen due to the high costs and technical complexity of the procedure. The small number of OD cycles could probably be attributed to the absence of legislation on this subject during the years included in the registry (the Portuguese Law on ART has only been released in July, 2006). bibliography 1. Vayena E, Rowe PJ, Grifin PD (2002). World Health Organization. Current practise and controversies in assisted reproduction. (2002). Geneva: World health Organization. 19 22; 2. Zegers-Hochschild F, Nygren KG, Adamson DG, de Mouzon J, Mansour R, Sullivan E (2006). The ICMART glossary on ART terminology. hum Reprod 21:1968 1970; 3. Zegers-Hochschild F, Nygren KG, Adamson D, De Mouzon J, Lancaster P, Mansour R, Sullivan E (2006). The International Committee Monitoring Assisted Reproductive Technologies (ICMART) glossary on ART terminology. Fertil Steril 86:16-19; 4. Nyboe Andersen A, Goossens V, Ferraretti AP, Bhattacharya S, Felberbaum R, de Mouzon J, Nygren KG - The European IVFmonitoring (EIM) Consortium, for the European Society of human Reproduction and Embryology (EShRE) (2008). Assisted reproductive technology in Europe, 2004: results generated from European registers by EShRE. hum. Reprod, 23: 756 771; 5. EShRE Capri Workshop Group (2001). Social determinants of human reproduction. hum Reprod 16:1518-1526; 6. Instituto Nacional de Estatística (2008). Statistics Portugal Population Data. www.ine.pt (accessed January 6th, 2008); 7. Nyboe Andersen A, Carlsen E, Loft A (2008). Trends in the use of intracytoplasmatic sperm injection marked variability between countries. hum Reprod update 14(6):593-604; 8. Jain T, Gupta RS (2007). Trends in the use of intracytoplasmic sperm injection in the united States. N Engl J Med 357:251-257. 35